Antipsychotics in older people without dementia
Journal Title: Journal of Geriatric Care and Research - Year 2017, Vol 4, Issue 2
Abstract
Antipsychotic use in older adults, although debated, has an important role to play when treating illnesses such as schizophrenia and mood disorders. Risk-benefits need to be considered in view of multiple comorbidities and polypharmacy which are common in older patients. It appears that in patients appropriately treated with adequate doses, there is evidence to support the use of antipsychotic drugs.
Authors and Affiliations
Anitha Howard, Sharmi Bhattacharyya
Keywords
Related Articles
- EP ID EP308074
- DOI -
- Views 54
- Downloads 0
Covert administration of medications in old age psychiatry: a reflection
Covert administration of medications is often observed as a controversial practice, which is used in psychiatry over the years, particularly for the management of challenging behaviours of patients without mental capacit...
A short report on point prevalence of delirium in hospitalised older adult patients in Auckland, New Zealand
Background: Delirium in hospitalised older persons is common and is correlated with adverse outcomes. Few studies of this have been done in New Zealand. This study aimed to measure prevalence of delirium in older adults...
Primary progressive aphasia: a case report on diagnostic issues
Primary progressive aphasia (PPA), a neurodegenerative condition of insidious onset which has language impairment as the most salient and significant initial feature may provide diagnostic challenges due to obstacles in...
Recovering Quality of Life (ReQoL) scale: linguistic validation in Malayalam, an Indian language
Recovering Quality of Life (ReQoL) is a self-reported measure of quality of life of people with mental illness, with a potential for use as a patient rated outcome measure. ReQoL in English has been designed and validate...
Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
Background: The donepezil-memantine combination is a US Food and Drug Administration (FDA)–approved medication to treat Alzheimer’s disease (AD). Galantamine is superior to donepezil because it is a positive allosteric m...